Back to top
more

Amedisys (AMED)

(Delayed Data from NSDQ)

$97.75 USD

97.75
409,224

+0.17 (0.17%)

Updated Jul 25, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Ecolab (ECL) Launches Roach Control Device for Food Outlets

by Zacks Equity Research

Ecolab's (ECL) latest device is expected to help the restaurant industry efficiently protect their brand reputation and eliminate any business and public health risk.

LHC Group (LHCG) Forays Into Tucson Market With New Buyout

by Zacks Equity Research

LHC Group (LHCG) agrees to buy two Casa de la Luz provider locations to expand its hospice service in the Tucson market.

    Here's Why You Should Invest in Integer Holdings (ITGR) Stock

    by Zacks Equity Research

    Integer Holdings (ITGR) continues to gain traction from portfolio management.

    NextGen (NXGN) Implements API to Aid COVID-19 Vaccination

    by Zacks Equity Research

    NextGen's (NXGN) API is expected to address the unique and evolving reporting needs of various states as they administer the COVID-19 vaccine.

    DVA vs. AMED: Which Stock Should Value Investors Buy Now?

    by Zacks Equity Research

    DVA vs. AMED: Which Stock Is the Better Value Option?

    Orthofix (OFIX) Launches OSCAR PRO System in the US & Europe

    by Zacks Equity Research

    Orthofix's (OFIX) latest innovation is expected to drive organic growth in its Global Orthopedics business.

    PerkinElmer (PKI) to Boost Immunodiagnostics Unit With Buyout

    by Zacks Equity Research

    PerkinElmer (PKI) enters into an agreement to acquire IDS, which will enable the former to grow its overall Diagnostics business, particularly its immunodiagnostics unit.

    QIAGEN (QGEN) Gains from FDA's EUA for Antibody Total Test

    by Zacks Equity Research

    QIAGEN's (QGEN) COVID-19 total antibody test processes up to 32 swab samples per hour.

    Here's Why You Should Add Inogen (INGN) to Your Portfolio

    by Zacks Equity Research

    Investors continue to be optimistic about Inogen (INGN) on its direct-to-customer business model and a strong product portfolio.

    BD's (BDX) First Self-Collection HPV Screening Assay Gets CE Mark

    by Zacks Equity Research

    BD's (BDX) industry-first CE marked self-collection claim for HPV screening enables greater access to testing for women.

    HCA Healthcare (HCA) to Divest Hospital for Better Liquidity

    by Zacks Equity Research

    HCA Healthcare (HCA) to sell Redmond Regional Medical Center, GA to AdventHealth for boosting financial solvency.

    PRA Health's (PRAH) New Solution to Speed Up Drug Development

    by Zacks Equity Research

    PRA Health's (PRAH) tokenization solution can help in the generation of enhanced evidence for drug development through Synoma.

    Here's Why You Should Retain Change Healthcare (CHNG) Stock

    by Zacks Equity Research

    Change Healthcare (CHNG) continues to benefit from robust payment accuracy business and strategic deals. However, intense competition remains a woe.

    Here's Why You Should Add Bruker (BRKR) to Your Portfolio

    by Zacks Equity Research

    Investors continue to be optimistic about Bruker (BRKR) on its slew of product launches and potential in the BSI Nano Group.

    Here's Why You Should Retain Intuitive Surgical (ISRG) Now

    by Zacks Equity Research

    Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System. However, rise in production costs is a woe.

    Here's Why You Should Buy Amedisys (AMED) Stock Now

    by Zacks Equity Research

    Investors are optimistic about Amedisys (AMED) on bright Personal Care prospects, and strategic acquisitions and partnerships.

    Amedisys (AMED) to Buy VNA Hospice, Home Health, Expand in NE

    by Zacks Equity Research

    The acquisition is going to expand Amedisys' (AMED) presence in Omaha and Council Bluffs' healthcare communities.

      Here's Why You Should Hold on to Illumina (ILMN) Stock for Now

      by Zacks Equity Research

      Investors continue to be optimistic about Illumina (ILMN), backed by its focus on partnerships and robust adoption of its products.

      Here's Why You Should Hold on to ResMed (RMD) Stock for Now

      by Zacks Equity Research

      Investors continue to be optimistic about ResMed (RMD), owing to its potential in digital health and consistent high demand for its masks.

      Medtronic (MDT) to Enhance Patient Care via Digital Portal

      by Zacks Equity Research

      Medtronic's (MDT) first patient-centric digital health platform is expected to provide better outcome for patients undergoing the company's SCS therapy.

      Henry Schein (HSIC) Hits New 52-Week High: What's Driving It?

      by Zacks Equity Research

      Henry Schein (HSIC) is optimistic about maintaining robust sales of PPE and COVID-19-related products.

      Amedisys (AMED) Q1 Earnings Beat Estimates, 2021 View Up

      by Zacks Equity Research

      Amedisys' (AMED) first-quarter 2021 revenues improves year over year on solid growth in the Home Health and Hospice divisions.

      Amedisys (AMED) to Report Q1 Earnings: What's in Store?

      by Zacks Equity Research

      Growth in Home Health and Hospice along with recent innovation and acquisitions is expected to have contributed to Amedisys (AMED) top-line growth in Q1.

      The Zacks Analyst Blog Highlights: Addus HomeCare, LHC Group and Amedisys

      by Zacks Equity Research

      The Zacks Analyst Blog Highlights: Addus HomeCare, LHC Group and Amedisys

      Sapna Bagaria headshot

      Biden Chips in $400B for Home Healthcare: Stocks to Watch

      by Sapna Bagaria

      Biden's support to expand access to long-term care services under Medicaid bodes well for companies providing home healthcare.